Management of neonatal abstinence syndrome focuses on what?

• A. Vitamin supplementation only
• B. Prophylactic antibiotics for all
• C. Immediate surgical intervention
• D. Supportive care and symptom control

Answer: (D)

Managing neonatal abstinence syndrome centers on supportive care and symptom control. NAS occurs when a newborn is exposed to opioids or other drugs in utero and then experiences withdrawal after birth. The goal is to ease irritability and tremors, improve feeding and sleep, and stabilize autonomic signs.

Nonpharmacologic care is foundational: provide a quiet, dim environment with minimal stimulation, use swaddling and gentle handling, encourage skin-to-skin contact when possible, and offer small, frequent feeds with careful monitoring of intake, weight, hydration, and temperature. Clinicians often use a scoring system to quantify severity and guide treatment decisions.

If symptoms are mild, supportive care alone can be sufficient. When withdrawal is moderate to severe or worsening, pharmacologic therapy typically begins with an opioid such as morphine or methadone, with a gradual taper as symptoms improve. Some cases may require adjunctive medications like phenobarbital or clonidine for persistent symptoms.

Breastfeeding is encouraged if the mother is stable and using opioids under medical supervision, as breast milk can help lessen withdrawal in the infant. Antibiotics, routine vitamin supplementation, or immediate surgical intervention are not standard treatments for NAS.